Honca M, Kose E A, Bulus H, Horasanli E
Acta Chir Belg. 2014 May-Jun;114(3):174-8. doi: 10.1080/00015458.2014.11681004.
The aim of this randomized controlled study was to compare the postoperative analgesic efficacy of intraperitoneal bupivacaine versus levobupivacaine in patients undergoing laparoscopic cholecystectomy.
We randomly divided 90 patients undergoing elective laparoscopic cholecystectomy into 3 groups. A dose of 0.125% bupivacaine (Group B) 80 ml or 0.125% levobupivacaine (Group L) 80 ml or 0.09% NaCl (Group P) 80 ml was instilled intraperitoneally at the end of the procedure, before removal of the trocars. All patients had a standard anesthetic. Tramadol was administered intravenously via a patient controlled analgesia pump as a rescue analgesic in all patients. Postoperative pain scores were assessed at 30 minutes, 1, 2, 4, 6, 12 and 24 hours after surgery by using a visual analog scale. The primary end point of this study was to compare tramadol consumption of the three groups at the postoperative 24 h. Total tramadol consumption, first analgesic requirement time and adverse effects were recorded.
Group B experienced significantly less pain (P < 0.01) than the placebo group at 6 h, 12 h and 24 h postoperatively during rest. Group L registered significantly lower visual analog scale scores (p < 0.01) than the placebo group at 12 h during rest. During movement, visual analog scale pain scores were lower in group B than Group P (P < 0.01). Additionally, total tramadol consumption was significantly lower in Group B than the other groups. First analgesic requirement time was shorter in the placebo group compared with group B and group L (P < 0.05). There was no significant difference between the groups with respect to right shoulder pain, total nausea and vomiting.
Intraperitoneal instillation of bupivacaine 0.125% 80 ml (100 mg) is more effective than levobupivacaine 0.125% 80 ml (100 mg) in reducing the postoperative pain after laparoscopic cholecystectomy.
本随机对照研究的目的是比较布比卡因与左旋布比卡因腹腔内注射对接受腹腔镜胆囊切除术患者的术后镇痛效果。
我们将90例行择期腹腔镜胆囊切除术的患者随机分为3组。在手术结束拔套管针前,向腹腔内注入80毫升0.125%布比卡因(B组)或80毫升0.125%左旋布比卡因(L组)或80毫升0.09%氯化钠(P组)。所有患者均采用标准麻醉。所有患者均通过患者自控镇痛泵静脉注射曲马多作为补救性镇痛药。术后30分钟、1、2、4、6、12和24小时使用视觉模拟量表评估术后疼痛评分。本研究的主要终点是比较三组术后24小时曲马多的消耗量。记录曲马多总消耗量、首次镇痛需求时间和不良反应。
术后6小时、12小时和24小时休息时,B组疼痛明显轻于安慰剂组(P<0.01)。L组在术后12小时休息时视觉模拟量表评分明显低于安慰剂组(P<0.01)。活动时,B组视觉模拟量表疼痛评分低于P组(P<0.01)。此外,B组曲马多总消耗量明显低于其他组。安慰剂组首次镇痛需求时间短于B组和L组(P<0.05)。三组在右肩疼痛、恶心呕吐总发生率方面无显著差异。
腹腔镜胆囊切除术后,腹腔内注入80毫升(100毫克)0.125%布比卡因比注入80毫升(100毫克)0.125%左旋布比卡因在减轻术后疼痛方面更有效。